US 8716315
Analogs of thalidomide as potential angiogenesis inhibitors
granted A61KA61K31/4035A61K31/454
Quick answer
US patent 8716315 (Analogs of thalidomide as potential angiogenesis inhibitors) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4035, A61K31/454, A61K31/506, A61K31/513